Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential

Epigenetic alterations are common in prostate cancer (PCa) and seem to contribute decisively to its initiation and progression. Moreover, aberrant promoter methylation is a promising biomarker for non-invasive screening. Herein, we sought to characterize EFEMP1 as biomarker for PCa, unveiling its bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Almeida, Mafalda, Costa, Vera L, Costa, Natália R, Ramalho-Carvalho, João, Baptista, Tiago, Ribeiro, Franclim R, Paulo, Paula, Teixeira, Manuel R, Oliveira, Jorge, Lothe, Ragnhild A, Lind, Guro E, Henrique, Rui, Jerónimo, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224561/
https://www.ncbi.nlm.nih.gov/pubmed/25211630
http://dx.doi.org/10.1111/jcmm.12394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224561/
https://www.ncbi.nlm.nih.gov/pubmed/25211630
http://dx.doi.org/10.1111/jcmm.12394

Ejemplares similares